Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial

Abstract

BACKGROUND Trigeminal neuralgia is characterized by paroxysmal facial pain attacks. Adequate prophylactic drug therapy is often limited by the lack of efficacy and intolerance due to central nervous system side effects. Subcutaneous injections of botulinum toxin type A are a promising treatment option for patients with unsatisfactory response to drug… (More)
DOI: 10.1186/s13063-015-1052-z

Topics

4 Figures and Tables

Cite this paper

@inproceedings{Burmeister2015BotulinumNT, title={Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial}, author={Jan Burmeister and Dagny Holle and Eva Bock and Claudia Ose and Hans-Christoph Diener and Mark Obermann}, booktitle={Trials}, year={2015} }